Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone
Read more here


Ossianix Expands and Extends its Research Collaboration with Lundbeck on CNS Therapeutics
Read More Here


Melior Discovery Awarded SBIR Grant for Studying MLR-1023 Mechanism of Action
Read more here


Relmada Therapeutics Receives Health Canada Clearance to Commence First Clinical Study of d-Methadone
Read more here


Novira Therapeutics Announces Presentation of Phase Ia Safety and Pharmacokinetic Data for NVR 3-778
Read more here


Relmada Therapeutics Appoints Michael Becker as Senior Vice President of Finance and Corporate Development
Read more here


Relmada Therapeutics Reinforces Balance Sheet with $15.2 Million from Exercise of Warrants
Read more here


Melior Pharmaceuticals Receives First Performance Milestone Payment from Bukwang Pharmaceutical
Read more here


Infrascanner™ Brain Scanner Gets $3.7M-Expands head trauma detection capabilities
Read more here